Shanghai Kinetic Medical Co., Ltd (SHE:300326)
China flag China · Delayed Price · Currency is CNY
6.13
-0.11 (-1.76%)
Sep 28, 2026, 3:04 PM CST

Shanghai Kinetic Medical Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
777.21963.06984.52956.261,1661,269
Revenue Growth
-26.31%-2.18%2.96%-17.99%-8.08%19.50%
Gross Profit
449.71475.9479.09490.17740.07778.06
Operating Income
85.5559.9379.1279.78212.26280.36
Net Income
225.01134.89-105.57112.54-21.28161.78
Earnings Per Share
0.310.19-0.150.16-0.030.22
EPS Growth
------

Revenue by Segment

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Jan '22
Medical Device Manufacturing
612.65559.41564.07850.89869.88
Medical Device Trading
100.11142.59155.63140.37194.9
Device Disinfection Service Industry
233.27260.74213.93155.01192.75
Unallocated Other Operations
17.0421.7822.6319.7711.06
Total
963.06984.52956.261,1661,269

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
1,6161,5171,2191,042971.89906.83
Total Debt
51.5354.22326.48196.83328.49425.62
Net Cash (Debt)
1,5641,462892.06844.84643.41481.21
Net Cash Growth
70.43%63.93%5.59%31.31%33.71%-10.92%
Net Cash Per Share
2.182.041.241.180.890.67

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
235.23189.09157.75274.26236.76378.16
Capital Expenditures
-33.15-66.2-82.84-53.79-41.45-49.21
Free Cash Flow
202.08122.8874.91220.47195.3328.94
Free Cash Flow Growth
165.98%64.04%-66.02%12.89%-40.63%28.84%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
57.86%49.41%48.66%51.26%63.47%61.33%
Operating Margin
11.01%6.22%8.04%8.34%18.20%22.10%
Pretax Margin
30.00%15.11%-11.21%13.97%-0.19%17.05%
Profit Margin
28.95%14.01%-10.72%11.77%-1.82%12.75%
FCF Margin
26.00%12.76%7.61%23.06%16.75%25.93%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
0.1000.100-0.060-0.050
Dividend Per Share Growth
0%----0%
Dividend Yield
1.63%1.79%-0.98%-0.49%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
19.5430.19-40.33-46.89
Forward PE
-32.9732.9725.8915.7326.00
P/FCF Ratio
21.7533.1462.2220.5926.4323.06
PS Ratio
5.664.234.734.754.435.98